Dose-Related Paresthesias With Venlafaxine

Conclusion: Clinicians need to be aware of the possible emergence of paresthesias with venlafaxine treatment, especially at doses of ≥150 mg/day. Patients who receive venlafaxine for pain disorders should be closely monitored for worsening of pain symptoms and may require adjustment of their doses.

http://jpp.sagepub.com/cgi/content/abstract/26/5/514?rss=1

Source: Journal of Pharmacy Practice - September 24, 2013 Category: Drugs & Pharmacology Authors: Angelo, L. J., Lee, K. C. Tags: Adverse Drug Event Source Type: research